Document 0463 DOCN M9490463 TI Successful treatment of a patient with seropositive human immunodeficiency virus with high risk Burkitt's leukemia. DT 9411 AU Greenberg AL; Droller DG; Department of Medicine, University of Miami School of Medicine,; Florida. SO Cancer. 1994 Aug 15;74(4):1261-4. Unique Identifier : AIDSLINE MED/94332776 AB A 24-year-old male patient seropositive for the human immunodeficiency virus with Burkitt's Leukemia was treated successfully with aggressive systemic chemotherapy and central nervous system prophylaxis. He presented with a leukocyte count of 68,900/microliter with 33% L3 lymphoblasts, massive hepatosplenomegaly, generalized lymphadenopathy, a lactic dehydrogenase level of 9105 IU/l, creatinine level of 5.8 mg/dl, and a uric acid level of 43.5 mg/dl. Hemodialysis, intrathecal methotrexate, hydrocortisone and cytosine arabinoside, and fractionated doses of cyclophosphamide followed by vincristine and doxorubicin were promptly instituted. He received eight subsequent courses of chemotherapy consisting of either methotrexate with leucovorin rescue and high dose, continuous infusion cytosine arabinoside or cyclophosphamide, vincristine, and methotrexate with leucovorin. There was marked hematologic toxicity resulting from this treatment. However, the patient was alive and in complete remission more than 6 years from diagnosis. This paper demonstrated that it is possible to successfully treat a patient who is HIV-1 antibody positive with poor prognosis Burkitt's Leukemia. Further studies need to be undertaken to define the least toxic, most effective therapy for this disease. DE Adult Antineoplastic Agents, Combined/ADMINISTRATION & DOSAGE/ *THERAPEUTIC USE Case Report Combined Modality Therapy Cyclophosphamide/ADMINISTRATION & DOSAGE Cytarabine/ADMINISTRATION & DOSAGE Doxorubicin/ADMINISTRATION & DOSAGE Hemodialysis Human Hydrocortisone/ADMINISTRATION & DOSAGE HIV Seropositivity/*COMPLICATIONS Injections, Intravenous Injections, Spinal Leukemia, B-Cell, Acute/*COMPLICATIONS/*DRUG THERAPY Male Methotrexate/ADMINISTRATION & DOSAGE Remission Induction Vincristine/ADMINISTRATION & DOSAGE JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).